Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura R Prakash

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Annals of Surgical Oncology|January 3, 2024
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium StudyDeesje Doppenberg, Thomas F Stoop, Susan van Dieren, et al.
Annals of Surgery|June 30, 2023
Prophylactic Antibiotic Duration and Infectious Complications in Pancreatoduodenectomy Patients With Biliary Stents: Opportunity for De-escalationArtem Boyev, Elsa M Arvide, Timothy E Newhook, et al.
Journal of the American College of Surgeons|January 5, 2024
Postoperative Global Period Cost Reduction Using 3 Successive Risk-Stratified Pancreatectomy Clinical PathwaysAhad Azimuddin, Ching-Wei D Tzeng, Laura R Prakash, et al.
Cancers|October 16, 2024
The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreaticoduodenectomyMehran Taherian, Matthew H G Katz, Laura R Prakash, et al.
Cancers|May 13, 2023
Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and PancreatectomyYi Tat Tong, Zongshan Lai, Matthew H G Katz, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 7, 2023
Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal CriteriaArtem Boyev, Ahad Azimuddin, Timothy E Newhook, et al.
Annals of Surgical Oncology|September 11, 2025
Association Between Intraoperative Hypothermia and Postoperative Pancreatic FistulaMaho Takayama, Rebecca A Snyder, Heather G Lyu, et al.
American Journal of Surgery|December 18, 2019
Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resectionEmily Z Keung, Elliot A Asare, Yi-Ju Chiang, et al.
Annals of Surgery|October 4, 2023
Classification of Post-pancreatectomy Readmissions and Opportunities for Targeted Mitigation StrategiesArtem Boyev, Ahad Azimuddin, Laura R Prakash, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 25, 2024
Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine TumorsChirayu Mohindroo, Seyda Baydogan, Parul Agarwal, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Annals of Surgical Oncology|January 3, 2024
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium StudyDeesje Doppenberg, Thomas F Stoop, Susan van Dieren, et al.
Annals of Surgery|June 30, 2023
Prophylactic Antibiotic Duration and Infectious Complications in Pancreatoduodenectomy Patients With Biliary Stents: Opportunity for De-escalationArtem Boyev, Elsa M Arvide, Timothy E Newhook, et al.
Journal of the American College of Surgeons|January 5, 2024
Postoperative Global Period Cost Reduction Using 3 Successive Risk-Stratified Pancreatectomy Clinical PathwaysAhad Azimuddin, Ching-Wei D Tzeng, Laura R Prakash, et al.
Cancers|October 16, 2024
The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreaticoduodenectomyMehran Taherian, Matthew H G Katz, Laura R Prakash, et al.
Cancers|May 13, 2023
Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and PancreatectomyYi Tat Tong, Zongshan Lai, Matthew H G Katz, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 7, 2023
Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal CriteriaArtem Boyev, Ahad Azimuddin, Timothy E Newhook, et al.
Annals of Surgical Oncology|September 11, 2025
Association Between Intraoperative Hypothermia and Postoperative Pancreatic FistulaMaho Takayama, Rebecca A Snyder, Heather G Lyu, et al.
American Journal of Surgery|December 18, 2019
Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resectionEmily Z Keung, Elliot A Asare, Yi-Ju Chiang, et al.
Annals of Surgery|October 4, 2023
Classification of Post-pancreatectomy Readmissions and Opportunities for Targeted Mitigation StrategiesArtem Boyev, Ahad Azimuddin, Laura R Prakash, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 25, 2024
Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine TumorsChirayu Mohindroo, Seyda Baydogan, Parul Agarwal, et al.
Pageof 7